CNS Disorders Flashcards
Disorders of the CNS can cause
Breakdown of the BBB
What forms the BBB?
Tight junctions
Barriers of the CNS
Arachnoid barrier
BBB
Blood-cerebrospinal fluid barrier
Transport pathways across the BBB
Paracellular—aqueous
Transcellular—lipophilic
Transport proteins—glucose, AA, nucleosides
Efflux pumps
Receptor mediated transcytosis—insulin, transferrin
Absorptive transcytosis—albumin, plasma proteins
Cell mediated transcytosis—monocytes, liposomes
How does the BBB prohibit transport?
1) physiochemical properties
—too large
—highly charged
—not lipophilic
2) multi-drug resistant transporters
—Pgp
—~50% all drugs
—upregulated in drug resistance
Passive strategies for nanoparticle drug delivery
Diffusion
Invasive approaches
Intracerebroventicular
Intrathecal
Intraparenchymal
Intracerebroventricular
Infusion into lateral ventricles
Circulation of CSF throughout brain
More invasive/higher risk
Intrathecal
Infusion into cisterna at site just below cerebellum, less commonly used clinically
Infusion into the lumbar region, commonly used in clinical sites with clinical trials ongoing
Pros to invasive approaches
Targeted
Much experience
Great promise based on animal studies
Cons of invasive approaches
Can be lethal
Less invasive than intraparenchymal (but still invasive)
Much experience (many failures)
Risk of infection
Intraparenchymal Infusion
Micro infusion pump infuses through cannula
Targeted to brain parenchyma
Continuous positive pressure
Pressure gradient provides convective flow
Limitations:
—highly invasive
—diffusion barrier
Diffusion barrier
Drugs must distribute through small brain extra cellular spaces for effect
Disruption of the BBB
Osmotic disruption
Chemical disruption
Ultrasound disruption
Osmotic disruption
Injection of high concentration of mannitol into carotid artery
Mannitol draws water from endothelial cells, resulting in shrinkage
Open tight junctions, allows for paracellular entry